286 citations,
January 2009 in “Human Reproduction Update” Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.
Metformin, commonly used for type 2 diabetes, is also prescribed for women with polycystic ovary syndrome (PCOS) to improve insulin resistance, menstrual regularity, and androgen levels, particularly in those with obesity or insulin resistance. While it may enhance fertility when combined with other treatments, it is not effective as a first-line therapy for weight loss, ovulation induction, or treating hyperandrogenic features like hirsutism or acne. During pregnancy, metformin may reduce early pregnancy loss and preterm birth, though its effects on gestational diabetes and preeclampsia are inconsistent. The review highlights the need for more high-quality research to better define the populations that benefit most from metformin and to assess long-term effects on children exposed to it during pregnancy.
100 citations,
May 2011 in “Journal of Pediatric and Adolescent Gynecology” The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.
October 2021 in “Acta Scientific Medical Sciences” A woman was diagnosed with a rare adrenal gland cancer that did not show usual hormone-related symptoms.
37 citations,
January 2008 in “Gynecological Endocrinology” Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.